Interferon alpha 2b (IFN) improves duration of complete remission (CR) and survival as maintenance therapy in patients with diffuse large cell lymphoma (DLCL)

✍ Scribed by Avilés, A.; Nambo, M.J.; Diaz-Maqueo, J.C.; Garcia, E.; Talavera, A.

• Book ID: 122428168
• Publisher: Elsevier Science
• Year: 1993
• Tongue: English
• Weight: 152 KB
• Volume: 29
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/0959-8049(93)91592-9